resources/kernel-4.0/samples/datacite-example-HasMetadata-v4.1.xml
<?xml version="1.0" encoding="UTF-8"?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
<identifier identifierType="DOI">10.5072/example</identifier>
<creators>
<creator>
<creatorName nameType="Personal">Mari, Bernard</creatorName>
<givenName>Bernard</givenName>
<familyName>Mari</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Puissegur, Marie-Pierre</creatorName>
<givenName>Marie-Pierre</givenName>
<familyName>Puissegur</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Barbry, Pascal</creatorName>
<givenName>Pascal</givenName>
<familyName>Barbry</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Lebrigand, Kevin</creatorName>
<givenName>Kevin</givenName>
<familyName>Lebrigand</familyName>
</creator>
</creators>
<titles>
<title xml:lang="en">
Identification of putative novel specific targets of mir-210 in A549 human adenocarcinoma cells
</title>
</titles>
<publisher>
Institut de Pharmacologie Moleculaire et Cellulaire (IPMC), CNRS UMR6097, Universite de Nice Sophia-Antipolis, 660 route des lucioles, 06560 Valbonne - Sophia-Antipolis, France
</publisher>
<publicationYear>2010</publicationYear>
<subjects>
<subject schemeURI="http://www.nlm.nih.gov/mesh/meshhome.html" subjectScheme="Mesh">Neoplasms</subject>
<subject schemeURI="http://purl.obolibrary.org/obo/obi" subjectScheme="OBI">Transcription profiling</subject>
<subject schemeURI="http://www.ncbi.nlm.nih.gov/Taxonomy/" subjectScheme="NCBITaxon">Homo sapiens</subject>
<subject schemeURI="http://www.ebi.ac.uk/efo" subjectScheme="Mesh">A549</subject>
<subject schemeURI="http://purl.obolibrary.org/obo/obi" subjectScheme="OBI">DNA microarray</subject>
</subjects>
<contributors>
<contributor contributorType="HostingInstitution">
<contributorName nameType="Organizational">INIST-CNRS</contributorName>
</contributor>
</contributors>
<language>en</language>
<resourceType resourceTypeGeneral="Text">Experiment report</resourceType>
<relatedIdentifiers>
<relatedIdentifier relatedIdentifierType="URL" relatedMetadataScheme="ISA-Tab" relationType="HasMetadata" schemeType="Text" schemeURI="http://isatab.sourceforge.net/docs/ISA-TAB_release-candidate-1_v1.0_24nov08.pdf">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE18695</relatedIdentifier>
</relatedIdentifiers>
<sizes>
<size>183 ko</size>
<size>3 pages</size>
</sizes>
<formats>
<format>PDF</format>
</formats>
<rightsList>
<rights rightsURI="http://creativecommons.org/licenses/by-nc-nd/3.0/">
Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported
</rights>
</rightsList>
<descriptions>
<description xml:lang="en" descriptionType="Abstract">
To identify putative novel specific targets of mir-210, we overexpressed miR-210 as well as miR-34a and a siRNA targeted against E2F3 in A549 human adenocarcinoma cells by transfecting them with synthetic pre-miRNAs or a synthetic negative pre-miRNA
as control (miR-Neg). RNA samples were harvested at 48 hours post-transfection and 2 independent experiments performed in dye-swap: miR-210 versus miR-Neg ; miR-34a versus miR-Neg ; si-E2F3 versus miR-Neg ; si-control versus miR-Neg.
</description>
</descriptions>
</resource>